| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | modified amino acid binding | 1.47e-04 | 122 | 82 | 5 | GO:0072341 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.03e-04 | 28 | 82 | 3 | GO:0001972 | |
| MousePheno | abnormal QT variability | 1.13e-05 | 10 | 65 | 3 | MP:0004156 | |
| Domain | UDPGT | 9.88e-05 | 21 | 81 | 3 | PF00201 | |
| Domain | UDPGT | 9.88e-05 | 21 | 81 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 9.88e-05 | 21 | 81 | 3 | IPR002213 | |
| Domain | NAD(P)-bd_dom | 9.34e-04 | 173 | 81 | 5 | IPR016040 | |
| Domain | adh_short | 1.75e-03 | 55 | 81 | 3 | PF00106 | |
| Domain | SH3_9 | 4.73e-03 | 78 | 81 | 3 | PF14604 | |
| Domain | Bromodomain_CS | 5.64e-03 | 26 | 81 | 2 | IPR018359 | |
| Domain | - | 6.27e-03 | 169 | 81 | 4 | 3.40.50.720 | |
| Domain | Alkaline_phosphatase_core | 7.96e-03 | 31 | 81 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 7.96e-03 | 31 | 81 | 2 | IPR017849 | |
| Domain | - | 7.96e-03 | 31 | 81 | 2 | 3.40.720.10 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 5.11e-05 | 15 | 70 | 3 | MM15697 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.26e-04 | 20 | 70 | 3 | MM14721 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.57e-04 | 55 | 70 | 4 | M14933 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.93e-04 | 23 | 70 | 3 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.20e-04 | 24 | 70 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.49e-04 | 25 | 70 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 2.49e-04 | 25 | 70 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.49e-04 | 25 | 70 | 3 | M605 | |
| Pathway | WP_GLUCURONIDATION | 2.81e-04 | 26 | 70 | 3 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 3.51e-04 | 28 | 70 | 3 | M19580 | |
| Pathway | KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM | 4.77e-04 | 31 | 70 | 3 | M766 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 5.25e-04 | 32 | 70 | 3 | MM14719 | |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 5.25e-04 | 32 | 70 | 3 | MM15446 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 6.68e-04 | 8 | 70 | 2 | M26991 | |
| Pubmed | JUP LRPPRC FASN SERPINB6 MIA3 COL12A1 GLG1 ACLY AHNAK SCARB1 SMC4 GATM KDM3B PSMC2 LAMB1 PTPN23 RRM1 TRRAP CBS PLS3 PIGO HSD17B8 | 1.89e-13 | 1297 | 82 | 22 | 33545068 | |
| Pubmed | JUP FASN ACLY RABEP1 AHNAK CGN DOCK7 SMC4 KDM3B PSMC2 PTPN23 RFX1 TRRAP PLS3 EP300 | 2.94e-12 | 549 | 82 | 15 | 38280479 | |
| Pubmed | NEPRO JUP FASN MIA3 SUPT5H ACLY AHNAK CGN DOCK7 SMC4 KDM3B PSMC2 | 1.77e-10 | 399 | 82 | 12 | 37536630 | |
| Pubmed | JUP LRPPRC FASN BAIAP2L1 ACLY AHNAK DOCK7 SMC4 PSMC2 PTPN23 CRYBG3 RRM1 ARHGEF26 PLS3 | 1.13e-09 | 708 | 82 | 14 | 39231216 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | JUP FASN UBE4B SUPT5H ACLY RABEP1 AHNAK THG1L SMC4 KDM3B PSMC2 LAMB1 PTPN23 SMS RRM1 CBS PLS3 | 4.13e-08 | 1455 | 82 | 17 | 22863883 |
| Pubmed | LRPPRC FASN SUPT5H ACLY AHNAK CGN DOCK7 SMC4 PSMC2 TRRAP NNT PHIP | 4.34e-08 | 653 | 82 | 12 | 22586326 | |
| Pubmed | JUP LRPPRC FASN BAIAP2L1 LUC7L3 ACLY AHNAK DOCK7 MRPL10 SMC4 PSMC2 CBS PLS3 | 5.40e-08 | 809 | 82 | 13 | 32129710 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 2.94e-07 | 24 | 82 | 4 | 24625756 | |
| Pubmed | 3.50e-07 | 190 | 82 | 7 | 24816252 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | JUP LRPPRC FASN LUC7L3 SUPT5H ACLY AHNAK CGN DOCK7 SMC4 TRRAP NNT PHIP | 7.89e-07 | 1024 | 82 | 13 | 24711643 |
| Pubmed | 7.96e-07 | 72 | 82 | 5 | 36376293 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF462 NEPRO JUP FASN MIA3 UBE4B GLG1 AHNAK SCARB1 GHITM DOCK7 GPC6 RFX1 NNT | 7.98e-07 | 1203 | 82 | 14 | 29180619 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | JUP LRPPRC BAIAP2L1 RABEP1 MAP4K1 AHNAK CGN DOCK7 KDM3B CRYBG3 MUSK MYLK2 | 8.31e-07 | 861 | 82 | 12 | 36931259 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | JUP LRPPRC FASN SERPINB6 BAIAP2L1 LUC7L3 GLG1 ACLY AHNAK SMC4 PSMC2 PTPN23 RRM1 CBS PLS3 | 9.88e-07 | 1415 | 82 | 15 | 28515276 |
| Pubmed | 1.05e-06 | 9 | 82 | 3 | 22511988 | ||
| Pubmed | 1.05e-06 | 9 | 82 | 3 | 1339448 | ||
| Pubmed | 1.50e-06 | 10 | 82 | 3 | 23642732 | ||
| Pubmed | 1.50e-06 | 10 | 82 | 3 | 11465080 | ||
| Pubmed | 1.50e-06 | 10 | 82 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.50e-06 | 10 | 82 | 3 | 22558097 | |
| Pubmed | 1.68e-06 | 469 | 82 | 9 | 37314180 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.92e-06 | 477 | 82 | 9 | 31300519 | |
| Pubmed | 2.74e-06 | 12 | 82 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 2.74e-06 | 12 | 82 | 3 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 3.55e-06 | 13 | 82 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 3.55e-06 | 13 | 82 | 3 | 25246029 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 4.33e-06 | 179 | 82 | 6 | 36261009 | |
| Pubmed | 4.51e-06 | 14 | 82 | 3 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 4.51e-06 | 14 | 82 | 3 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 4.51e-06 | 14 | 82 | 3 | 14672974 | |
| Pubmed | 4.51e-06 | 14 | 82 | 3 | 9295054 | ||
| Pubmed | 4.58e-06 | 397 | 82 | 8 | 21319273 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 8068691 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 34323067 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24641623 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 26934656 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 14570768 | ||
| Pubmed | 6.68e-06 | 418 | 82 | 8 | 34709266 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 6.92e-06 | 16 | 82 | 3 | 19414484 | |
| Pubmed | 6.92e-06 | 16 | 82 | 3 | 24804215 | ||
| Pubmed | 7.04e-06 | 560 | 82 | 9 | 35241646 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 8.39e-06 | 17 | 82 | 3 | 20639394 | |
| Pubmed | 9.35e-06 | 312 | 82 | 7 | 37120454 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.02e-05 | 208 | 82 | 6 | 33230847 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.19e-05 | 19 | 82 | 3 | 23281178 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.37e-05 | 219 | 82 | 6 | 31353912 | |
| Pubmed | 1.40e-05 | 220 | 82 | 6 | 24550385 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.40e-05 | 220 | 82 | 6 | 35785414 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | JUP LRPPRC FASN SERPINB6 UBE4B ACLY AHNAK SMC4 PSMC2 PTPN23 RRM1 TRRAP PHIP | 1.62e-05 | 1353 | 82 | 13 | 29467282 |
| Pubmed | Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue. | 1.64e-05 | 3 | 82 | 2 | 28255813 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 21281598 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 37377173 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 12051676 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 21726077 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 37801083 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 23611809 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 21383159 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | LRPPRC FASN SUPT5H ACLY GHITM SMC4 PSMC2 LAMB1 PTPN23 SMS PLS3 | 1.79e-05 | 974 | 82 | 11 | 28675297 |
| Pubmed | 1.98e-05 | 638 | 82 | 9 | 33239621 | ||
| Pubmed | 2.34e-05 | 70 | 82 | 4 | 21726808 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | JUP FASN SERPINB6 BAIAP2L1 GLG1 ACLY AHNAK GHITM PTPN23 SLC4A4 NEB | 2.64e-05 | 1016 | 82 | 11 | 19056867 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | JUP LRPPRC FASN LUC7L3 SUPT5H ACLY DOCK7 SMC4 DNAH5 NNT CBS PLS3 PHIP | 2.79e-05 | 1425 | 82 | 13 | 30948266 |
| Pubmed | 2.80e-05 | 25 | 82 | 3 | 36708875 | ||
| Pubmed | 3.22e-05 | 255 | 82 | 6 | 15324660 | ||
| Pubmed | The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex. | 3.28e-05 | 4 | 82 | 2 | 12743606 | |
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 3.28e-05 | 4 | 82 | 2 | 18223459 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 12644700 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 9535849 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 9271343 | ||
| Pubmed | CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells. | 3.28e-05 | 4 | 82 | 2 | 26657156 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 14519497 | ||
| Pubmed | 3.42e-05 | 382 | 82 | 7 | 37249651 | ||
| Pubmed | 3.97e-05 | 28 | 82 | 3 | 18839057 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 3.99e-05 | 265 | 82 | 6 | 19240061 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 4.26e-05 | 704 | 82 | 9 | 29955894 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF462 BDP1 LRPPRC SERPINB6 MIA3 LUC7L3 UBE4B ZNF827 RABEP1 SCARB1 ARHGEF26 TRRAP EP300 | 4.38e-05 | 1489 | 82 | 13 | 28611215 |
| Pubmed | 4.81e-05 | 551 | 82 | 8 | 34728620 | ||
| Pubmed | Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. | 5.47e-05 | 5 | 82 | 2 | 37163372 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 10972938 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 7677729 | ||
| Pubmed | CTGF/CCN2 facilitates LRP4-mediated formation of the embryonic neuromuscular junction. | 5.47e-05 | 5 | 82 | 2 | 32558157 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 17576800 | ||
| Pubmed | Role of ZBP-89 in human globin gene regulation and erythroid differentiation. | 5.47e-05 | 5 | 82 | 2 | 21828133 | |
| Pubmed | Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation. | 5.47e-05 | 5 | 82 | 2 | 19244212 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 15057901 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 34048454 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 25810523 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 6.08e-05 | 175 | 82 | 5 | 25756610 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 6.23e-05 | 922 | 82 | 10 | 27609421 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 6.40e-05 | 422 | 82 | 7 | 27342126 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | 6.46e-05 | 926 | 82 | 10 | 20877624 | |
| Pubmed | Autophagosomal Content Profiling Reveals an LC3C-Dependent Piecemeal Mitophagy Pathway. | 6.55e-05 | 33 | 82 | 3 | 29149599 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.93e-05 | 934 | 82 | 10 | 33916271 | |
| Pubmed | 7.21e-05 | 754 | 82 | 9 | 35906200 | ||
| Pubmed | GRAMD1B LRPPRC SERPINB6 MIA3 GLG1 RABEP1 DOCK7 PSMC2 SYP CRYBG3 SLC4A4 | 7.40e-05 | 1139 | 82 | 11 | 36417873 | |
| Pubmed | 8.10e-05 | 186 | 82 | 5 | 14744259 | ||
| Pubmed | 8.12e-05 | 952 | 82 | 10 | 38569033 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 8.19e-05 | 6 | 82 | 2 | 26025922 | |
| Pubmed | CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. | 8.19e-05 | 6 | 82 | 2 | 19805293 | |
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 17050673 | ||
| Interaction | KCNA3 interactions | JUP LRPPRC FASN AFF2 BAIAP2L1 ACLY AHNAK CGN VPS13A DOCK7 SMC4 PSMC2 PTPN23 CRYBG3 RRM1 ARHGEF26 DNAH5 PLS3 | 1.00e-08 | 871 | 82 | 18 | int:KCNA3 |
| Interaction | MOB3C interactions | NEPRO JUP FASN MIA3 SUPT5H ACLY AHNAK CGN DOCK7 SMC4 KDM3B PSMC2 | 2.68e-08 | 364 | 82 | 12 | int:MOB3C |
| Interaction | PIH1D1 interactions | JUP LRPPRC FASN SERPINB6 GLG1 ACLY MAP4K1 AHNAK DOCK7 SMC4 RRM1 CBS PLS3 | 7.51e-06 | 731 | 82 | 13 | int:PIH1D1 |
| Interaction | TULP3 interactions | 1.14e-05 | 346 | 82 | 9 | int:TULP3 | |
| Interaction | EMC2 interactions | 4.40e-05 | 411 | 82 | 9 | int:EMC2 | |
| Interaction | SIRT7 interactions | LRPPRC FASN SUPT5H ACLY AHNAK CGN DOCK7 SMC4 PSMC2 TRRAP NNT PHIP | 4.54e-05 | 744 | 82 | 12 | int:SIRT7 |
| Interaction | STIP1 interactions | LRPPRC FASN NRBP2 ACLY MAP4K1 AHNAK SMC4 PSMC2 PTPN23 NEB RRM1 CBS PLS3 EP300 | 5.01e-05 | 1006 | 82 | 14 | int:STIP1 |
| Interaction | NEK7 interactions | 5.02e-05 | 161 | 82 | 6 | int:NEK7 | |
| Interaction | MYH9 interactions | JUP LRPPRC AHNAK DOCK7 SMC4 KDM3B PSMC2 PEX5L TRRAP DNAH5 NNT EP300 | 5.16e-05 | 754 | 82 | 12 | int:MYH9 |
| Interaction | FDPS interactions | 6.16e-05 | 167 | 82 | 6 | int:FDPS | |
| Interaction | AAR2 interactions | LRPPRC FASN SERPINB6 LUC7L3 ACLY AHNAK PSMC2 PTPN23 RRM1 CBS PLS3 | 6.96e-05 | 657 | 82 | 11 | int:AAR2 |
| Interaction | PPP2R1A interactions | LRPPRC FASN LUC7L3 WDR7 SUPT5H ACLY SMC4 PSMC2 PTPN23 PLS3 EP300 | 7.75e-05 | 665 | 82 | 11 | int:PPP2R1A |
| Interaction | DUSP13B interactions | 7.92e-05 | 108 | 82 | 5 | int:DUSP13B | |
| Interaction | ATXN7 interactions | 8.27e-05 | 109 | 82 | 5 | int:ATXN7 | |
| Interaction | TRIM33 interactions | 9.28e-05 | 453 | 82 | 9 | int:TRIM33 | |
| Interaction | PYHIN1 interactions | 1.04e-04 | 358 | 82 | 8 | int:PYHIN1 | |
| Interaction | ADRM1 interactions | 1.05e-04 | 266 | 82 | 7 | int:ADRM1 | |
| Interaction | PSMD10 interactions | 1.15e-04 | 187 | 82 | 6 | int:PSMD10 | |
| Interaction | PDIA3 interactions | 1.35e-04 | 476 | 82 | 9 | int:PDIA3 | |
| Interaction | NBR1 interactions | 1.57e-04 | 380 | 82 | 8 | int:NBR1 | |
| Interaction | UGT1A3 interactions | 1.62e-04 | 5 | 82 | 2 | int:UGT1A3 | |
| Interaction | NUP210L interactions | 1.62e-04 | 5 | 82 | 2 | int:NUP210L | |
| Interaction | HSF1 interactions | 1.78e-04 | 609 | 82 | 10 | int:HSF1 | |
| Interaction | AHCY interactions | 1.92e-04 | 293 | 82 | 7 | int:AHCY | |
| Interaction | FGD5 interactions | 2.00e-04 | 207 | 82 | 6 | int:FGD5 | |
| Cytoband | 2q37 | 2.38e-05 | 31 | 82 | 3 | 2q37 | |
| GeneFamily | UDP glucuronosyltransferases | 1.17e-04 | 32 | 54 | 3 | 363 | |
| GeneFamily | Dyneins, axonemal | 1.16e-03 | 17 | 54 | 2 | 536 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 1.52e-03 | 76 | 54 | 3 | 743 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.89e-06 | 200 | 82 | 6 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.75e-06 | 147 | 82 | 5 | 2d9044ddf01b6838a44a4518b442d7e7cb0bf910 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 1.36e-05 | 165 | 82 | 5 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 1.36e-05 | 165 | 82 | 5 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 173 | 82 | 5 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 173 | 82 | 5 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 173 | 82 | 5 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-05 | 179 | 82 | 5 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.35e-05 | 185 | 82 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.41e-05 | 186 | 82 | 5 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 187 | 82 | 5 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-05 | 187 | 82 | 5 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.48e-05 | 187 | 82 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 189 | 82 | 5 | 0493f7b79127c207fd7ade778ef4810500495d7e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 2.60e-05 | 189 | 82 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-05 | 190 | 82 | 5 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-05 | 195 | 82 | 5 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.02e-05 | 195 | 82 | 5 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.10e-05 | 196 | 82 | 5 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 3.10e-05 | 196 | 82 | 5 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.10e-05 | 196 | 82 | 5 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-05 | 197 | 82 | 5 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.18e-05 | 197 | 82 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 3.25e-05 | 198 | 82 | 5 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.25e-05 | 198 | 82 | 5 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.33e-05 | 199 | 82 | 5 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | normal_Pleural_Fluid-Epithelial_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.33e-05 | 199 | 82 | 5 | 564ba7acd03be2d6e4d0850cb2c7237a788dc275 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 200 | 82 | 5 | 3a954d9d542e52c9b181f0850a09b1bff0a0c82d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial-Astrocyte|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 200 | 82 | 5 | 7c66953ff6d8f16f4decd23c85232990d2d8c6c4 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT1|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.41e-05 | 200 | 82 | 5 | 3a9633f5913f12b6865fc777c84f3f3ba795a78d | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.70e-04 | 150 | 82 | 4 | 6a13e4c4b9c9e54a5016573a37132465ec1c8f99 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-04 | 155 | 82 | 4 | 0fd66c623cb433ceaa893bc21ba2e3b394faaf70 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-04 | 157 | 82 | 4 | a633fb8e7a009490c6002bf272eceaf317f27af6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 158 | 82 | 4 | d72d6527dc50207ddbada262460d3c4bac249a19 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-04 | 159 | 82 | 4 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 164 | 82 | 4 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 164 | 82 | 4 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_PSRC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 165 | 82 | 4 | 6de69b75174731931e7e80a3488f983a7ba4defe | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.44e-04 | 165 | 82 | 4 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 167 | 82 | 4 | b5d15773be32cd277125fd3b4056a8fefaefa5ec | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-04 | 169 | 82 | 4 | 780fb0050852626062a729dd1b82b0cf61e7e9ca | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-04 | 169 | 82 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 2.67e-04 | 169 | 82 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tox_(Neuron.Slc17a7.Syt6-Tox)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.68e-04 | 68 | 82 | 3 | b8d472ff47312a8cc8ba60809947c82f4054d8de | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tox_(Neuron.Slc17a7.Syt6-Tox)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.68e-04 | 68 | 82 | 3 | 94acd088e39a17cd573aa3ad533b6634e3b7018d | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Syt6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.68e-04 | 68 | 82 | 3 | 89929e9e3a119f6eafef37a401e8fe2bd972452b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-04 | 170 | 82 | 4 | 5de2f7d16a05af74ebfb1ca42d0f9c3c3524692d | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-04 | 171 | 82 | 4 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-04 | 172 | 82 | 4 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 172 | 82 | 4 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 172 | 82 | 4 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-04 | 173 | 82 | 4 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-04 | 173 | 82 | 4 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.92e-04 | 173 | 82 | 4 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.99e-04 | 174 | 82 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.05e-04 | 175 | 82 | 4 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-04 | 175 | 82 | 4 | 7be76d39e1a4f4ac709672cd2d409a2523a083ce | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.12e-04 | 176 | 82 | 4 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.19e-04 | 177 | 82 | 4 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.33e-04 | 179 | 82 | 4 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-04 | 179 | 82 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-04 | 180 | 82 | 4 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 3.40e-04 | 180 | 82 | 4 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 180 | 82 | 4 | 7d3d5608647b6e684e8e185993d106a38c53e76a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-04 | 181 | 82 | 4 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-04 | 181 | 82 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.47e-04 | 181 | 82 | 4 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.47e-04 | 181 | 82 | 4 | 88f6f56f5f58b479d5db91b32c45934c045f88ea | |
| ToppCell | E18.5-samps|World / Age Group, Lineage, Cell class and subclass | 3.54e-04 | 182 | 82 | 4 | 9649f15858d1ede73e068afc59df3ac367b49687 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.54e-04 | 182 | 82 | 4 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-04 | 182 | 82 | 4 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | facs-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 182 | 82 | 4 | 45faefd7cbeac84d2c58650530b902af6ce921f8 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 3.54e-04 | 182 | 82 | 4 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-04 | 183 | 82 | 4 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 3.62e-04 | 183 | 82 | 4 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-04 | 183 | 82 | 4 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 3.62e-04 | 183 | 82 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 3.62e-04 | 183 | 82 | 4 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.69e-04 | 184 | 82 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | 04bd8ab5808fcfa923aa4d0edf6a7f88b7980122 | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|normal_Lung / Location, Cell class and cell subclass | 3.69e-04 | 184 | 82 | 4 | 7ee98acda030366ac6cf3890a6d93fd0426712ed | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.69e-04 | 184 | 82 | 4 | ca940a4f4970285ed284d5517d142abab0682044 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 184 | 82 | 4 | 34e316ad8e7b8667cd8ad61397281802a252744f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R-_NK_cell|lymphoid / Lineage, cell class and subclass | 3.69e-04 | 184 | 82 | 4 | 62a3918705a3fcf3ef25c9ceb80f575a2e56ef76 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 3.69e-04 | 184 | 82 | 4 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.69e-04 | 184 | 82 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | e727bf110cb6a91a655c1865b0e93e51e2f9dda3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-04 | 185 | 82 | 4 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.77e-04 | 185 | 82 | 4 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 3.77e-04 | 185 | 82 | 4 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-04 | 185 | 82 | 4 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.77e-04 | 185 | 82 | 4 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.85e-04 | 186 | 82 | 4 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 186 | 82 | 4 | fa5f602f01de5beec529d9f5208172b2914a952d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 186 | 82 | 4 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| Drug | AC1L9DGV | 1.85e-07 | 36 | 82 | 5 | CID000417381 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 2.07e-07 | 15 | 82 | 4 | CID000040469 | |
| Drug | tectochrysin | 7.25e-07 | 20 | 82 | 4 | CID005281954 | |
| Drug | amonafide | 1.09e-06 | 22 | 82 | 4 | CID000050515 | |
| Drug | N-phenylmaleimide | 1.87e-06 | 25 | 82 | 4 | CID000013662 | |
| Drug | DiMeIQx | 2.57e-06 | 27 | 82 | 4 | CID000104739 | |
| Drug | N-hydroxy-4-aminobiphenyl | 3.00e-06 | 28 | 82 | 4 | CID000081261 | |
| Drug | H-Ni | 3.00e-06 | 28 | 82 | 4 | CID000445665 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 3.47e-06 | 29 | 82 | 4 | CID005375667 | |
| Drug | AC1MRQNQ | 3.72e-06 | 9 | 82 | 3 | CID003522271 | |
| Drug | DHPASiU | 3.72e-06 | 9 | 82 | 3 | CID000197602 | |
| Drug | Chebi:32663 | 3.72e-06 | 9 | 82 | 3 | CID005460873 | |
| Drug | 3-iodophenol | 3.72e-06 | 9 | 82 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 3.72e-06 | 9 | 82 | 3 | CID000186631 | |
| Drug | ethoxytriethyleneglycol | 4.03e-06 | 66 | 82 | 5 | CID000008190 | |
| Drug | PCB 156 | 4.57e-06 | 31 | 82 | 4 | CID000038019 | |
| Drug | indole-2-carboxylic acid | 5.20e-06 | 32 | 82 | 4 | CID000072899 | |
| Drug | 6-methylsalicylic acid | 5.91e-06 | 33 | 82 | 4 | CID000011279 | |
| Drug | 4-nitrophenyl)imidazole | 7.28e-06 | 11 | 82 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 7.28e-06 | 11 | 82 | 3 | CID006442661 | |
| Drug | glucoraphanin | 8.43e-06 | 36 | 82 | 4 | CID000656556 | |
| Drug | 16-epiestriol | 8.64e-06 | 77 | 82 | 5 | CID000003269 | |
| Drug | l-borneol | 9.43e-06 | 37 | 82 | 4 | CID000010049 | |
| Drug | N-OH-DABZ | 9.68e-06 | 12 | 82 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 9.68e-06 | 12 | 82 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 9.68e-06 | 12 | 82 | 3 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 9.68e-06 | 12 | 82 | 3 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 9.68e-06 | 12 | 82 | 3 | CID000160090 | |
| Drug | Glucose | FASN COL12A1 BAIAP2L1 WDR7 ACLY THG1L VPS13A SMC4 SYP LAMB1 SMS RET NNT CBS PLS3 PHIP EP300 | 1.00e-05 | 1420 | 82 | 17 | ctd:D005947 |
| Drug | tritanol | 1.25e-05 | 13 | 82 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.25e-05 | 13 | 82 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.25e-05 | 13 | 82 | 3 | CID000000411 | |
| Drug | afloqualone | 1.28e-05 | 2 | 82 | 2 | ctd:C033541 | |
| Drug | propranolol glucuronide | 1.59e-05 | 14 | 82 | 3 | CID000119515 | |
| Drug | PCB-61 | 1.59e-05 | 14 | 82 | 3 | CID000036401 | |
| Drug | N-hydroxy-PhIP | 1.73e-05 | 43 | 82 | 4 | CID000104954 | |
| Drug | 7,8-benzoquinoline | 1.73e-05 | 43 | 82 | 4 | CID000009191 | |
| Drug | anthraflavic acid | 1.90e-05 | 44 | 82 | 4 | CID000006776 | |
| Drug | coumarin-3-carboxylic acid | 1.99e-05 | 15 | 82 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 1.99e-05 | 15 | 82 | 3 | CID000543743 | |
| Drug | afloqualone | 1.99e-05 | 15 | 82 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 1.99e-05 | 15 | 82 | 3 | CID000114775 | |
| Drug | ethoxyresorufin | 2.41e-05 | 95 | 82 | 5 | CID000003294 | |
| Drug | quercetin-3,4'-diglucoside | 2.44e-05 | 16 | 82 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 2.44e-05 | 16 | 82 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.44e-05 | 16 | 82 | 3 | CID005497144 | |
| Drug | kaempferol | 2.66e-05 | 97 | 82 | 5 | CID005280863 | |
| Drug | EM-652 | 2.93e-05 | 49 | 82 | 4 | CID000155435 | |
| Drug | campestrol | 2.93e-05 | 49 | 82 | 4 | CID000010134 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 2.95e-05 | 17 | 82 | 3 | CID000003573 | |
| Drug | 6-hydroxychrysene | 2.95e-05 | 17 | 82 | 3 | CID000037766 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 3.53e-05 | 18 | 82 | 3 | CID000152226 | |
| Drug | Br 2 | 3.53e-05 | 18 | 82 | 3 | CID003060900 | |
| Drug | SureCN12722713 | 3.53e-05 | 18 | 82 | 3 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 3.53e-05 | 18 | 82 | 3 | CID000036614 | |
| Drug | ApApG | 3.53e-05 | 18 | 82 | 3 | CID003081975 | |
| Drug | C1 11-32 | 3.53e-05 | 18 | 82 | 3 | CID000443077 | |
| Drug | C11131 | 3.53e-05 | 18 | 82 | 3 | CID000443076 | |
| Drug | almokalant | 4.19e-05 | 19 | 82 | 3 | CID003033962 | |
| Drug | 9-OH-risperidone | 4.19e-05 | 19 | 82 | 3 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 4.19e-05 | 19 | 82 | 3 | CID000091433 | |
| Drug | tangeretin | 4.31e-05 | 54 | 82 | 4 | CID000068077 | |
| Drug | oleoyl-estrone | 4.63e-05 | 55 | 82 | 4 | ctd:C108709 | |
| Drug | AC1L1OBF | 4.91e-05 | 20 | 82 | 3 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 4.91e-05 | 20 | 82 | 3 | CID000116545 | |
| Drug | estriol-16-glucuronide | 5.71e-05 | 21 | 82 | 3 | CID000122281 | |
| Drug | dulcin | 5.71e-05 | 21 | 82 | 3 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 5.71e-05 | 21 | 82 | 3 | CID000069186 | |
| Drug | phenolphthalein | 5.72e-05 | 58 | 82 | 4 | CID000004764 | |
| Drug | N-methylpiperazine | 6.60e-05 | 22 | 82 | 3 | CID000053167 | |
| Drug | benzphetamine | 7.09e-05 | 119 | 82 | 5 | CID000002341 | |
| Drug | amidoxime | 7.57e-05 | 23 | 82 | 3 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 7.57e-05 | 23 | 82 | 3 | CID000066651 | |
| Drug | phenanthridine | 7.57e-05 | 23 | 82 | 3 | CID000009189 | |
| Drug | dimethyl itaconate | 7.65e-05 | 4 | 82 | 2 | CID000069240 | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 6596_DN | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; PC3; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 6638_DN | |
| Drug | PhIP-HCl | 8.30e-05 | 123 | 82 | 5 | CID000001530 | |
| Drug | AS-3201 | 8.63e-05 | 24 | 82 | 3 | CID000153948 | |
| Drug | Polychlorinated Biphenyls | 9.08e-05 | 633 | 82 | 10 | ctd:D011078 | |
| Drug | 5-MOP | 9.78e-05 | 25 | 82 | 3 | CID000002355 | |
| Drug | AzMC | 9.78e-05 | 25 | 82 | 3 | CID000064986 | |
| Drug | N-acetylbenzidine | 9.78e-05 | 25 | 82 | 3 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 9.78e-05 | 25 | 82 | 3 | CID000006796 | |
| Drug | Aroclor 1254 | 1.21e-04 | 213 | 82 | 6 | CID000040470 | |
| Drug | diflunisal | 1.24e-04 | 27 | 82 | 3 | CID000003059 | |
| Drug | naringenin | 1.33e-04 | 136 | 82 | 5 | CID000000932 | |
| Drug | CARMINE | 1.38e-04 | 28 | 82 | 3 | CID000014749 | |
| Drug | AC1Q5PO8 | 1.38e-04 | 28 | 82 | 3 | CID000000642 | |
| Drug | erucin | 1.38e-04 | 28 | 82 | 3 | CID000078160 | |
| Drug | pyruvic acid | 1.45e-04 | 424 | 82 | 8 | CID000001060 | |
| Drug | gemfibrozil | 1.52e-04 | 222 | 82 | 6 | CID000003463 | |
| Drug | AC1L1JAL | 1.54e-04 | 29 | 82 | 3 | CID000004954 | |
| Drug | 2-acetylpyridine | 1.54e-04 | 29 | 82 | 3 | CID000014286 | |
| Drug | trans-3'-hydroxycotinine | 1.54e-04 | 29 | 82 | 3 | CID000000414 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.54e-04 | 29 | 82 | 3 | CID000125641 | |
| Drug | iberin | 1.54e-04 | 29 | 82 | 3 | CID000010455 | |
| Drug | N-benzylformamide | 1.65e-04 | 76 | 82 | 4 | CID000080654 | |
| Drug | trifluoperazine | 1.69e-04 | 324 | 82 | 7 | CID000005566 | |
| Drug | tolcapone | 1.70e-04 | 30 | 82 | 3 | CID004659569 | |
| Disease | serum metabolite measurement | TINAGL1 UGT1A4 UGT1A3 DMGDH LRPPRC UGT1A5 SCARB1 DNAH17 GHITM DOCK7 GATM LAMB1 CBS MUSK | 1.65e-07 | 945 | 78 | 14 | EFO_0005653 |
| Disease | metabolite measurement | TINAGL1 UGT1A4 ZNF462 UGT1A3 DMGDH DHRS4L1 UGT1A5 SCARB1 GATM SLC13A5 MUSK | 2.57e-07 | 560 | 78 | 11 | EFO_0004725 |
| Disease | X-11793--oxidized bilirubin measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 9.86e-07 | 8 | 78 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 1.48e-06 | 9 | 78 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.48e-06 | 9 | 78 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.48e-06 | 9 | 78 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.48e-06 | 9 | 78 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.48e-06 | 9 | 78 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.48e-06 | 9 | 78 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.48e-06 | 9 | 78 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.48e-06 | 9 | 78 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.48e-06 | 9 | 78 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 2.10e-06 | 10 | 78 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 2.10e-06 | 10 | 78 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 2.10e-06 | 10 | 78 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 2.10e-06 | 10 | 78 | 3 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 2.89e-06 | 11 | 78 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.89e-06 | 11 | 78 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.89e-06 | 11 | 78 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.89e-06 | 11 | 78 | 3 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 3.84e-06 | 12 | 78 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 3.84e-06 | 12 | 78 | 3 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 4.99e-06 | 13 | 78 | 3 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.18e-05 | 17 | 78 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 1.41e-05 | 18 | 78 | 3 | EFO_0801382 | |
| Disease | tissue factor measurement | 2.28e-05 | 21 | 78 | 3 | EFO_0010623 | |
| Disease | citrate measurement | 5.84e-05 | 79 | 78 | 4 | EFO_0010114 | |
| Disease | xanthurenate measurement | 6.18e-05 | 29 | 78 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 6.85e-05 | 30 | 78 | 3 | EFO_0600017 | |
| Disease | cholelithiasis | 8.90e-05 | 88 | 78 | 4 | EFO_0004799 | |
| Disease | level of Phosphatidylinositol (18:1_18:2) in blood serum | 1.03e-04 | 6 | 78 | 2 | OBA_2045160 | |
| Disease | 1-stearoyl-2-linoleoyl-GPC (18:0/18:2) measurement | 1.03e-04 | 6 | 78 | 2 | EFO_0800404 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) measurement | 1.44e-04 | 7 | 78 | 2 | EFO_0800609 | |
| Disease | bilirubin measurement | 1.71e-04 | 442 | 78 | 7 | EFO_0004570 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement | 1.91e-04 | 8 | 78 | 2 | EFO_0800610 | |
| Disease | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement | 1.91e-04 | 8 | 78 | 2 | EFO_0800396 | |
| Disease | level of Phosphatidylinositol (16:0_18:2) in blood serum | 1.91e-04 | 8 | 78 | 2 | OBA_2045153 | |
| Disease | gallstones | 1.97e-04 | 108 | 78 | 4 | EFO_0004210 | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0800439 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0800412 | |
| Disease | level of Phosphatidylcholine (18:0_20:5) in blood serum | 2.45e-04 | 9 | 78 | 2 | OBA_2045095 | |
| Disease | 1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement | 3.06e-04 | 10 | 78 | 2 | EFO_0800469 | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 3.06e-04 | 10 | 78 | 2 | OBA_2045075 | |
| Disease | apolipoprotein B measurement | 3.66e-04 | 663 | 78 | 8 | EFO_0004615 | |
| Disease | pregnenetriol sulfate measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0600039 | |
| Disease | cholesterol to total lipids in large HDL percentage | 4.22e-04 | 55 | 78 | 3 | EFO_0022234 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 4.48e-04 | 12 | 78 | 2 | OBA_2045152 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 4.48e-04 | 12 | 78 | 2 | OBA_2045157 | |
| Disease | urate measurement, spine bone mineral density | 4.94e-04 | 58 | 78 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | melanoma | 5.16e-04 | 248 | 78 | 5 | C0025202 | |
| Disease | pregnenetriol disulfate measurement | 5.28e-04 | 13 | 78 | 2 | EFO_0800587 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 5.28e-04 | 13 | 78 | 2 | OBA_2045159 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 5.28e-04 | 13 | 78 | 2 | EFO_0800413 | |
| Disease | non-high density lipoprotein cholesterol measurement | 5.91e-04 | 713 | 78 | 8 | EFO_0005689 | |
| Disease | free cholesterol in very large HDL measurement | 6.01e-04 | 62 | 78 | 3 | EFO_0022273 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 6.15e-04 | 14 | 78 | 2 | EFO_0022085 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 6.15e-04 | 14 | 78 | 2 | OBA_2045100 | |
| Disease | delta-6 desaturase measurement | 7.08e-04 | 15 | 78 | 2 | EFO_0007765 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 7.08e-04 | 15 | 78 | 2 | OBA_2045131 | |
| Disease | Non-Small Cell Lung Carcinoma | 7.91e-04 | 156 | 78 | 4 | C0007131 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement | 8.08e-04 | 16 | 78 | 2 | EFO_0800184 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 8.08e-04 | 16 | 78 | 2 | OBA_2045090 | |
| Disease | X-21441 measurement | 9.14e-04 | 17 | 78 | 2 | EFO_0800814 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 1.03e-03 | 18 | 78 | 2 | OBA_2045155 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 1.03e-03 | 18 | 78 | 2 | OBA_2045065 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 1.15e-03 | 19 | 78 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.20e-03 | 447 | 78 | 6 | C3714756 | |
| Disease | serum homoarginine measurement | 1.27e-03 | 20 | 78 | 2 | EFO_0005421 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 1.27e-03 | 20 | 78 | 2 | OBA_2045071 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.34e-03 | 307 | 78 | 5 | EFO_0004612, EFO_0020946 | |
| Disease | non-alcoholic fatty liver disease | 1.40e-03 | 182 | 78 | 4 | EFO_0003095 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 1.40e-03 | 21 | 78 | 2 | OBA_2045156 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 1.40e-03 | 21 | 78 | 2 | OBA_2045076 | |
| Disease | thyroxine measurement | 1.40e-03 | 83 | 78 | 3 | EFO_0005130 | |
| Disease | hormone measurement | 1.45e-03 | 84 | 78 | 3 | EFO_0004730 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.61e-03 | 189 | 78 | 4 | EFO_0009932 | |
| Disease | sorbitol measurement | 1.68e-03 | 23 | 78 | 2 | EFO_0010533 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 1.68e-03 | 23 | 78 | 2 | OBA_2045158 | |
| Disease | apolipoprotein A 1 measurement | 1.79e-03 | 848 | 78 | 8 | EFO_0004614 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.83e-03 | 91 | 78 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | vitamin D measurement | 1.99e-03 | 336 | 78 | 5 | EFO_0004631 | |
| Disease | Dwarfism | 1.99e-03 | 25 | 78 | 2 | C0013336 | |
| Disease | Adenocarcinoma of large intestine | 2.13e-03 | 96 | 78 | 3 | C1319315 | |
| Disease | level of Phosphatidylcholine (17:0_20:4) in blood serum | 2.15e-03 | 26 | 78 | 2 | OBA_2045087 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.20e-03 | 206 | 78 | 4 | C0152013 | |
| Disease | dihomo-gamma-linolenic acid measurement | 2.32e-03 | 27 | 78 | 2 | EFO_0007763 | |
| Disease | Vitiligo | 2.46e-03 | 101 | 78 | 3 | EFO_0004208 | |
| Disease | mean corpuscular hemoglobin concentration | 2.52e-03 | 1105 | 78 | 9 | EFO_0004528 | |
| Disease | Colorectal Carcinoma | 2.57e-03 | 702 | 78 | 7 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MVSEIPEKKAMAIAD | 311 | P35503 | |
| QPSQEVKMEAKMEVD | 971 | Q09472 | |
| DIPIMEKVSGKMAVV | 1261 | A6H8Y1 | |
| IIQQPMKEEKVASLM | 231 | Q5FYA8 | |
| VSMDNTVVIEDIKKM | 171 | Q8WYN0 | |
| VKTEMTPVTVDMENI | 1656 | Q68DQ2 | |
| PIIQPMEVQMKVKTN | 561 | P51816 | |
| PEMIIQKPKISMQDV | 491 | Q09666 | |
| MNIKVPKISMPDVDL | 811 | Q09666 | |
| KNRMSQPVLKVVMED | 336 | Q96DR7 | |
| IDNIMGEKIEMIAPV | 321 | Q3KR37 | |
| SVVMPMEKEIAALKD | 186 | Q15276 | |
| VMLVSEAEMEKQKVA | 1286 | Q9H3S7 | |
| QKMIDMAEPAQRKII | 1006 | Q8TB72 | |
| LMPENVVEEKTKAMD | 326 | Q9NSY0 | |
| MFPVKVKVEKSELEM | 1 | Q96GY3 | |
| MVDANEVPIQKMFEK | 371 | P50440 | |
| ALEPSMEKIFKIDQM | 66 | Q9H3K2 | |
| KALALMIKAVVPEME | 146 | P0CG22 | |
| FEKEMAVPDSLLMKV | 321 | Q96MA6 | |
| DLVEVKPKMVMTVFA | 606 | P13797 | |
| PKDKEMVLLEIEVMN | 321 | Q9H1R3 | |
| PIMNGKDVVAIIMAV | 181 | P16499 | |
| RAADKAVAMVMKEIP | 36 | Q8IYB4 | |
| DTQKEVKEMVMGLNV | 1361 | Q7LBC6 | |
| LIKDVTEMMAQVEVK | 1256 | P07942 | |
| KVEEAQGMMKLVEQL | 151 | O95232 | |
| MKGDVENIEVVQKML | 1151 | P42704 | |
| MEVMNLMEQPIKVTE | 1 | P14923 | |
| QKVFKLQETEMMDPE | 861 | Q92896 | |
| VMDPIDVKISEAIMN | 311 | Q9Y625 | |
| DAIKVPEKIMNMIEE | 231 | Q9UHR4 | |
| TVKMKEHQEDPEMLI | 1656 | Q96N67 | |
| ISIMEKTQPMKVQVE | 416 | Q99715 | |
| EKIPETFNMAEIMAK | 4206 | Q9UFH2 | |
| PQKVVDKITEMIPMG | 211 | Q92506 | |
| IIVMPEKMSSEKVDV | 166 | P35520 | |
| AAMEMVPVLKKADII | 351 | Q9UI17 | |
| QVEMTPEKFSVLMEK | 461 | Q9HB96 | |
| AVENMPSLKMKVVEV | 1231 | P49327 | |
| KVADMVKTGVIMNII | 521 | Q86YT5 | |
| KMTVFIDDVNMPIIN | 2651 | Q8TE73 | |
| CEQNVEVMLTPEMIK | 776 | Q4G0U5 | |
| KMVKMEPDDDVSTLQ | 46 | Q92918 | |
| PVLFNKEMIESMKEG | 326 | Q13423 | |
| KIDPTVTMMQVEEKP | 156 | P35998 | |
| DVKMATDPENIIKEM | 166 | P08247 | |
| CEIVKLKPKMVTMVE | 206 | P52788 | |
| KEIMKELMENGPVQA | 351 | Q9GZM7 | |
| QKMAMLQEEPVIVKP | 1631 | Q5JRA6 | |
| MVNIPEEMLRVKVAA | 726 | P22670 | |
| VMAIFKMITPEDVKL | 126 | P35243 | |
| MTMETLPKVLEVDEK | 1 | P0C851 | |
| VSMPVIQTKEKMIHE | 511 | Q6NW34 | |
| LFKVSKNEEKPVQMM | 186 | P35237 | |
| AVMIVMVPSLIKQQV | 26 | Q8WTV0 | |
| NQQMVPIKEMTDVLK | 251 | O00267 | |
| AKPMAKMQVEVEKQN | 451 | B3KU38 | |
| KEILIPVFKNMADAM | 546 | P53396 | |
| KVSLVLEKMQPLVMV | 336 | Q9P2M7 | |
| VDMEPKVINQMLSKA | 66 | Q9UJT1 | |
| LEDETVATVMPMKIQ | 1301 | A0JNW5 | |
| VPKGEMIKMNIDSIF | 1716 | Q96RL7 | |
| QGIEDKITKMKVTMV | 416 | Q8WWQ0 | |
| NMLLVSEEPKVKEMV | 151 | Q7Z7H8 | |
| MDFVDPAQITMKVIQ | 31 | P23921 | |
| VDEVMTKEIKLPTEM | 246 | Q9NWX6 | |
| MMANDAKPDVKTVQV | 1 | Q9H0I9 | |
| VAKLVEVMFMTNPAV | 931 | O95155 | |
| MVSEIPEKKAMAIAD | 311 | P35504 | |
| EVEQIAMMKPKGQTE | 231 | Q9NTJ3 | |
| PVFADISKDLEKMMV | 996 | P07949 | |
| ETQMVKIKEEPMEVD | 666 | Q17R98 | |
| MNVEVVKVMPQDLVT | 1 | Q9BX82 | |
| IMENSVKMPSIEEKE | 2456 | Q96JM2 | |
| PEMAKKLSQMDQVIQ | 246 | Q8TEQ8 | |
| KVPSIKIPMDIMEQQ | 1041 | Q9Y6R1 | |
| LMMQKFEKVPESKVI | 1566 | P01266 | |
| KMPTDVVDLLVEVMD | 1316 | Q9Y4E6 | |
| VNTPDETKLKMMQEV | 31 | Q9Y4A5 | |
| ERPEVQKQMLVDMAK | 101 | Q96MV8 | |
| MVSEIPEKKAMAIAD | 311 | P22310 | |
| EPFTMVAVKMLKEEA | 601 | O15146 | |
| IVPDMVEMVTAKDSQ | 4791 | P20929 |